Literature DB >> 24931814

Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.

M Tyblova1, T Kalincik, V Zikan, E Havrdova.   

Abstract

BACKGROUND AND
PURPOSE: The prevalence of osteopenia and osteoporosis is higher amongst patients with multiple sclerosis in comparison with the general population. In addition to the general determinants of bone health, two factors may contribute to reduced bone mineral density in multiple sclerosis: physical disability and corticosteroid therapy. The aim of this study was to examine the effect of physical disability and steroid exposure on bone health in weight-bearing bones and spine and on the incidence of low-trauma fractures in multiple sclerosis.
METHODS: In this retrospective analysis of prospectively collected data, associations between bone mineral density (at the femoral neck, total femur and the lumbar spine) and its change with disability or cumulative steroid dose were evaluated with random-effect models adjusted for demographic and clinical determinants of bone health. The incidence of low-trauma fractures during the study follow-up was evaluated with Andersen-Gill models.
RESULTS: Overall, 474 and 438 patients were included in cross-sectional and longitudinal analyses (follow-up 2347 patient-years), respectively. The effect of severely impaired gait was more apparent in weight-bearing bones (P ≤ 10(-15) ) than in spine (P = 0.007). The effect of cumulative steroid dose was relatively less pronounced but diffuse (P ≤ 10(-4) ). Risk of low-trauma fractures was associated with disability (P = 0.02) but not with cumulative steroid exposure and was greater amongst patients with severely impaired gait (annual risk 3.5% vs. 3.0%). Synergistic effects were found only between cumulative steroid dose in patients ambulatory without support (P = 0.02).
CONCLUSIONS: Bone health and the incidence of low-trauma fractures in multiple sclerosis are more related to impaired gait than to extended corticosteroid therapy.
© 2014 The Author(s) European Journal of Neurology © 2014 EAN.

Entities:  

Keywords:  bone mineral density; corticosteroids; disability; metabolism; multiple sclerosis

Mesh:

Substances:

Year:  2014        PMID: 24931814     DOI: 10.1111/ene.12479

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  4 in total

Review 1.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

2.  Lack of Association between Pulse Steroid Therapy and Bone Mineral Density in Patients with Multiple Sclerosis.

Authors:  Serap Zengin Karahan; Cavit Boz; Sevgi Kilic; Nuray Can Usta; Mehmet Ozmenoglu; Vildan Altunayoglu Cakmak; Sibel Gazioglu
Journal:  Mult Scler Int       Date:  2016-02-04

3.  Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D3.

Authors:  Natalia Niedziela; Krystyna Pierzchała; Jolanta Zalejska-Fiolka; Jacek T Niedziela; Ewa Romuk; Magdalena Torbus-Paluszczak; Monika Adamczyk-Sowa
Journal:  Biomed Res Int       Date:  2018-08-23       Impact factor: 3.411

4.  The effect of high-dose steroid treatment used for the treatment of acute demyelinating diseases on endothelial and cardiac functions.

Authors:  Mehmet Vedat Çaldır; Güner Koyuncu Çelik; Özgür Çiftçi; İbrahim Haldun Müderrisoğlu
Journal:  Anatol J Cardiol       Date:  2016-12-01       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.